Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Synopsys funds relentless R&D, books multi-year license revenue, or discloses its latest IP acquisition can feel like decoding a 300-page textbook. That complexity is why questions such as “Synopsys SEC filings explained simply” or “Synopsys insider trading Form 4 transactions” appear so often in search boxes.
Stock Titan solves the puzzle. Our platform delivers AI-powered summaries that turn every Synopsys annual report 10-K simplified, each Synopsys quarterly earnings report 10-Q filing, and even the briefest Synopsys 8-K material events explained into clear narrative. Need real-time alerts? Synopsys Form 4 insider transactions real-time show exactly when executives exercise options, while the dashboard links directly to Synopsys executive stock transactions Form 4 for deeper context. You’ll also find side-by-side Synopsys proxy statement executive compensation tables and concise Synopsys earnings report filing analysis, all updated the moment EDGAR releases.
The result: faster insight into how EDA tools, semiconductor IP, and software-security services shape revenue streams; instant visibility on share repurchases or option grants; and confidence when comparing backlog trends quarter-over-quarter. Whether you’re monitoring dilution risk, studying segment margins, or simply understanding Synopsys SEC documents with AI, every filing type—10-K, 10-Q, 8-K, S-8, or Form 4—is ready when you are, explained in language that empowers decisive action.
Synopsys insider activity: Janet Lee, Synopsys director and GC & Corporate Secretary, received 700 restricted stock units that vested on 09/01/2025 and that will convert into 700 shares subject to a March 1, 2027 final vesting schedule with subsequent quarterly installments. To satisfy tax withholding on the vested installment, the company retained 305 shares at an average withholding value of $603.52, leaving the reporting person with 8,693 shares after the transactions. The retained shares were approved by the Compensation Committee and were not more than the reported tax liability.
Ghazi Sassine, President and CEO and a director of Synopsys, reported multiple transactions in SNPS common stock on Form 4. The filing shows acquisitions on 08/29/2025 of shares under the Employee Stock Purchase Plan and on 09/02/2025 via exercise of a non-qualified stock option for 11,366 shares at a $89.76 exercise price. The same day (09/02/2025) 11,366 shares were sold in multiple transactions at prices ranging from $585.19 to $591.265, with a weighted average sale price of $589.0133. Reported beneficial ownership levels changed from 82,981 shares after the option exercise to 71,615 shares following the sale. The trades were effected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2024.
Synopsys insider purchase by CFO: This Form 4 shows Shelagh Glaser, identified as an officer (CFO) and director, acquired 26 shares of Synopsys, Inc. (SNPS) common stock on 08/29/2025 under the company's Employee Stock Purchase Plan at a price of $376.771 per share. After the transaction she beneficially owns 15,317 shares. The filing is signed by power of attorney Liz Ramirez for Shelagh Glaser on 09/03/2025. The report is filed by one reporting person and cites the ESPP as the acquisition source.
Synopsys insider purchase under ESPP: Sudhindra Kankanwadi, identified as an officer serving as Chief Accounting Officer, reported an acquisition of 26 shares of Synopsys Inc. (SNPS) common stock on 08/29/2025 under the company’s Employee Stock Purchase Plan at a reported price of $376.771 per share. After the transaction, the filing shows Mr. Kankanwadi beneficially owns 20,520 shares directly. The Form 4 was signed by a power of attorney on 09/03/2025. The filing is a routine Section 16 disclosure of an employee-plan purchase and contains no additional financial or forward-looking information.
Insider purchase filed on Form 4 for Synopsys, Inc. (SNPS). Aart de Geus, Executive Chair and Director, reported acquiring 26 shares of Synopsys common stock on 08/29/2025 at a price of $376.771 per share through the company Employee Stock Purchase Plan. After the transaction, Mr. de Geus is shown as beneficially owning 117,586 shares directly, plus 308,791 shares held indirectly by a family trust and 14,500 shares held indirectly by a partnership. The Form 4 was signed by power of attorney on 09/03/2025. The filing documents a routine ESPP purchase and updates aggregate insider holdings.
Richard S. Mahoney, Chief Revenue Officer of Synopsys, Inc. (SNPS), reported an acquisition of company common stock under the Employee Stock Purchase Plan on 08/29/2025. The form shows he purchased 26 shares at a price of $376.771 per share. After the transaction his beneficial ownership is reported as 1,511 shares, held directly. The filing was submitted via power of attorney by Liz Ramirez on 09/03/2025. No derivative transactions or additional changes are disclosed.
Synopsys Inc. (SNPS) filed a Form 144 notifying a proposed sale of 11,366 common shares via Morgan Stanley Smith Barney LLC on 09/02/2025. The filing shows an aggregate market value of $6,694,724.03 and total shares outstanding of 155,160,938. The shares were acquired the same day through a stock option exercise from the issuer, with payment made in cash. No securities sales by the reporting person were reported in the prior three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Synopsys (SNPS) – Form 4 insider update
On 31 Jul 2025 Director Ajei Gopal converted 117,256 restricted stock units into common shares at a $0 exercise price. To cover tax obligations, 46,153 shares were automatically withheld and sold back to the company at $633.47, a transaction valued at roughly $29.3 million. Net of withholding, his direct ownership rose by 71,103 shares, taking his total stake to 166,606 shares.
Per the separation agreement cited in the filing, all of Gopal’s remaining unvested RSUs were accelerated and vested in connection with his termination of employment. The dispositions were strictly for tax-withholding purposes; no open-market sales were reported.
FAQ
What is the current stock price of Synopsys (SNPS)?
What is the market cap of Synopsys (SNPS)?
